Evidence map›Paper›PMID 38464296›Full record

ArticlebioRxiv : the preprint server for biology2024

Epigenetic programming of host lipid metabolism associates with resistance to TST/IGRA conversion after exposure to

Kimberly A Dill-McFarland, Jason D Simmons, Glenna J Peterson, Felicia K Nguyen, Monica Campo, Penelope Benchek, Catherine M Stein, Tomas Vaisar, Harriet Mayanja-Kizza, W Henry Boom and 1 more

Open access · greenAbstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Kimberly A Dill-McFarlandDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0003-1481-7065
Jason D SimmonsDepartment of Medicine, University of Washington, Seattle, WA, USA.ORCID 0000-0002-7669-2803
Glenna J PetersonDepartment of Medicine, University of Washington, Seattle, WA, USA.
Felicia K NguyenDepartment of Medicine, University of Washington, Seattle, WA, USA.
Monica CampoDepartment of Medicine, University of Washington, Seattle, WA, USA.
Penelope BenchekDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
Catherine M SteinDepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
Tomas VaisarDepartment of Medicine, University of Washington, Seattle, WA, USA.
Harriet Mayanja-KizzaDepartment of Internal Medicine, Makerere University, Kampala, Uganda.
W Henry BoomDepartment of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
Thomas R HawnDepartment of Medicine, University of Washington, Seattle, WA, USA.
University of Idaho · USCase Western Reserve University · USMakerere University · UG

Funding

Vector and Transgenic Mouse CoreP30DK017047 · NIDDK · UNIVERSITY OF WASHINGTON · PI Sakeneh Zraika · 1986 to 2026
$41.4M
Role of Serum Amyloid A in Diabetic Vascular DiseaseP01HL092969 · NHLBI · UNIVERSITY OF WASHINGTON · PI GOLDBERG, IRA J · 2008 to 2019
$23.5M
HOST DEFENSE TRAINING IN ALLERGY AND INFECTIOUS DISEASEST32AI007044 · NIAID · UNIVERSITY OF WASHINGTON · PI DAVID Neal FREDRICKS · 1985 to 2026
$14.6M
Resistance to MTB infection in HIV infected individuals in Uganda and S. AfricaR01AI124348 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY, HAWN, THOMAS R · 2016 to 2020
$11.3M
Natural Resistance to Mycobacterium Tuberculosis InfectionU01AI115642 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BOOM, W. HENRY, MAYANJA-KIZZA, HARRIET · 2015 to 2019
$3.5M
Epigenetic & Post-Translational Mechanisms of Macrophage Resistance to Mycobacterium tuberculosis During HIV Co-InfectionR33AI138272 · NIAID · UNIVERSITY OF WASHINGTON · PI BOOM, W. HENRY, HAWN, THOMAS R · 2020 to 2022
$3.4M
Macrophages and Resistance to Mycobacterium Tuberculosis Infection in HumansK08AI143926 · NIAID · UNIVERSITY OF WASHINGTON · PI SIMMONS, JASON · 2019 to 2023
$951k
Pulmonary Innate Immunity & Resistance to Mycobacterium Tuberculosis InfectionK24AI137310 · NIAID · UNIVERSITY OF WASHINGTON · PI HAWN, THOMAS R · 2018 to 2022
$892k
NHLBI NIH HHS P01 HL092969NIAID NIH HHS K08 AI143926NIAID NIH HHS K24 AI137310NIAID NIH HHS R01 AI124348NIAID NIH HHS R33 AI138272NIAID NIH HHS T32 AI007044NIAID NIH HHS U01 AI115642NIDDK NIH HHS P30 DK017047
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38464296
PMCPMC10925331
OpenAlexW4392364765

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.